If you need more lookups,
subscriptions start at $34 USD/month.
Johan Lund Location
Stockholm, SE
Johan Lund Work
Co-founder and Chairman of the Board @ (June 2025 - Present)
Interim Chief Executive Officer and co-founder @ (October 2023 - June 2025)
Chairman of the Board @ (December 2025 - Present)
Chief Scientific Officer @ (March 2021 - Present)
Chairman Of The Board @ (June 2018 - June 2022)
Chairman of the Board of Directors @ (June 2019 - Present)
Member Board Of Directors @ (June 2021 - Present)
Venture Partner @ (December 2025 - Present)
Founder @ MBS Pharma (January 2018 - Present)
CEO and Co-Founder @ NeuVentis Therapeutics AB (August 2018 - Present)
Board member @ (June 2017 - August 2024)
Member Board Of Directors @ (June 2022 - January 2024)
Member Board Of Directors @ Genagon Therapeutics (May 2019 - January 2024)
Vice President @ (March 2016 - May 2017)
Board Member @ EIT Health Scandinavian CLC (June 2015 - March 2016)
Senior Specialist and Program Lead EIT Health @ (May 2015 - March 2016)
Managing Partner @ J. Lund & Associates, LLC (April 2015 - March 2016)
Senior Vice President and Chief Scientific Officer, Immunoscience Research Unit @ (August 2012 - March 2015)
Vice President @ (September 2008 - August 2012)
Vice President @ (October 2007 - September 2008)
Vice president @ (October 2005 - October 2007)
Director @ (November 2003 - October 2005)
Director @ (January 2000 - November 2003)
Director @ (January 1999 - January 2000)
Professor @ (January 1996 - January 1999)
Associate Professor @ (January 1990 - January 1996)
Research Fellow @ (June 1987 - September 1989)
Johan Lund Education
Karolinska Institutet
MD/PhD
1978-1986
Johan Lund Skills
Leadership
Development
PowerPoint
Clinical Trials
Drug Design
High Throughput Screening
Medical Writing
Translational Medicine
Public Speaking
CRO
In Vivo
Pharmaceutical Research
Neuroscience
Infectious Diseases
Early Development
Scandinavian
Drug Metabolism
Assay Development
Biotechnology
Cell
IND
Business Development
Immunology
Inflammation
ADME
DMPK
Translational Research
Drug Discovery
Molecular Biology
Microsoft Office
Lifesciences
Drug Delivery
Organic Chemistry
High Throughput
Oncology
Lead Change
Drug Development
GCP
Clinical Development
In Vitro
Customer Service
Pharmacodynamics
Regulatory Submissions
Cancer
Pharmacology
Medicinal Chemistry
Vaccines
Management
Research
Pharmaceutical Industry
Science
Biochemistry
Technology Transfer
GLP
Therapeutic Areas
Toxicology
Biomarkers
R&D
Protein Chemistry
Pharmacokinetics
Medical Affairs
Biopharmaceuticals
Strategic Planning
Microsoft Excel
Sales
Strategy
Johan Lund Summary
Johan Lund, based in Stockholm, SE, is currently a Chief Scientific Officer at AQILION AB. Johan Lund brings experience from previous roles at Mesenkia Therapeutics AB, PharmNovo and AQILION AB. Johan Lund holds a 1978 - 1986 MD/PhD @ Karolinska Institutet. With a robust skill set that includes Leadership, Development, PowerPoint, Clinical Trials, Drug Design and more. Johan Lund has 2 emails on RocketReach.
Looking for a different Johan Lund?
Find contact details for 700 million professionals.